Proteomic biomarkers of heart failure FINAL.pdf (683.4 kB)
Download file

Proteomic biomarkers of heart failure

Download (683.4 kB)
journal contribution
posted on 04.06.2018, 13:40 by M. Zubair Israr, Liam HeaneyLiam Heaney, Toru Suzuki
Heart failure (HF) is associated with significant morbidity and mortality. Biomarkers are used to assist clinicians with timely diagnosis, prognosis and risk prediction of patients for personalized treatment. Using modern proteomic methods such as mass spectrometry, an increasing number of novel biomarkers have been identified that further aid clinicians in the early diagnosis and outcome prediction of HF. This review focuses on the array of common and novel protein-based biomarkers which provide diagnostic and prognostic information in HF.

History

School

  • Sport, Exercise and Health Sciences

Published in

Heart Failure Clinics

Volume

14

Issue

1

Pages

93 - 107

Citation

ISRAR, M.Z., HEANEY, L.M. and SUZUKI, T., 2018. Proteomic biomarkers of heart failure. Heart Failure Clinics, 14(1), pp. 93-107.

Publisher

© Elsevier

Version

AM (Accepted Manuscript)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/

Acceptance date

01/09/2017

Publication date

2018

Notes

This paper was accepted for publication in the journal Heart Failure Clinics and the definitive published version is available at https://doi.org/10.1016/j.hfc.2017.08.010

ISSN

1551-7136

Language

en